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Heme oxygenase-1 (HO-1) is an inducible rate-controlling enzyme of heme catabolism. The
cytoprotective function of HO-1 activity has been verified in multiple studies, and together
with its by-products is considered a key component of the cellular stress response. The
transcriptional induction of HO-1 has been largely studied in response to multiple forms of
stressful stimuli but our understanding of HO-1 post-transcriptional control mechanisms in
neuronal cells is currently lacking. In the present report we show the involvement of the
RNA-binding proteins (RBPs) embryonic lethal abnormal vision (ELAV) in the regulation
of HO-1 gene expression. Our study demonstrates a specific binding between HO-1
messenger RNA (mRNA) and ELAV proteins, accompanied by an increased expression of
HO-1 at protein level, in a human neuroblastoma cell line treated with hemin. Clarifying
the induction of HO-1 expression at post-transcriptional level may open therapeutic
perspectives for treatments associated with the modulation of HO-1 expression.
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INTRODUCTION
Heme oxygenase-1 (HO-1) is an intracellular enzyme that
catalyzes the initial and rate-limiting step in the oxidative degra-
dation of heme, and generates biliverdin, free iron (Fe2+),
and carbon monoxide (CO; Calabrese et al., 2006). HO-1 is
a heat shock protein (HSP32) and it is recognized as one of
the major stress-inducible protein in mammalian cells (Maines,
1997). HO-1 activity can increase several-fold in response to
a wide variety of stimuli that cause changes in the cellular
redox state (Ryter and Choi, 2002). The products of heme
metabolism such as bilirubin, ferritin and CO, mediate many
of the anti-inflammatory and antioxidant effects associated with
the potent cytoprotection provided by HO-1 enzymatic system
(Kirkby and Adin, 2006). HO-1 expression is induced ubiq-
uitously in response to oxidative challenges but brain tissue
is particularly susceptible to free radical damage (Poon et al.,
2004). Indeed, there is an increasing support that HO-1 plays
a crucial protective role in the central nervous system (CNS),
primarily in astrocytes and microglia/macrophages, particularly
during aging and in several disease states where oxidative stress
is implicated, including Alzheimer’s disease (AD), Parkinson’s
disease (PD) and Huntington’s disease (HD; Calabrese et al.,
2004). Although numerous published reports have demonstrated
multiple beneficial effects of HO-1, its mechanism of action
has not been completely elucidated. Expression of HO-1 is reg-
ulated essentially at transcriptional level, even though a post-
transcriptional modulation of HO-1 messenger RNA (mRNA)
in distinct cellular contexts has been described (Gozzelino et al.,
2010). For instance, in human dermal fibroblasts hypoxia reg-
ulates HO-1 gene expression by a specific post-transcriptional
mechanism: stabilization of mRNA (Kitamuro et al., 2003).
Therefore, the regulation of HO-1 mRNA levels in response
to cellular stress may be induced by both transcriptional and
post-transcriptional events that act independently, and vary in
function of the stress inducer (Leautaud and Demple, 2007).
Although post-transcriptional control mechanisms are not yet
fully understood, it is clear that they are key determinants in
the regulation of mRNA stability and translation (Bolognani and
Perrone-Bizzozero, 2008; Pascale et al., 2008; Keene, 2010). In
particular, RNA-binding proteins (RBPs) regulate gene expression
at post-transcriptional level and influence pre-mRNA process-
ing as well as transport, localization, stability and translation
of target mRNAs (Dreyfuss et al., 2002). RBPs are crucial in
many aspects of cellular physiology and may play a direct role
in the pathophysiology of neurodegenerative diseases (Pascale
and Govoni, 2012; Perrone-Bizzozero and Bird, 2013; Romano
and Buratti, 2013). Recent studies have identified hundreds of
RBPs previously unknown (Castello et al., 2012) and a new
and fascinating idea is that neurons have their own systems for
regulating RNA metabolism, processing, localization, and expres-
sion (Darnell, 2013). In this context, embryonic lethal abnormal
vision (ELAV) proteins are RBPs mostly expressed in neurons and
post-transcriptional regulation in neuronal cells strongly depends
on the control exerted by these RBPs (Pascale et al., 2008). In
vertebrates, the ELAV (or Hu) family comprises the neuron-
specific members HuB, HuC and HuD, and the ubiquitously
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expressed HuR (Colombrita et al., 2013). Moreover, emerging
insights into the regulation by which cells establish patterns of
gene expression suggest that post-transcriptional events influence
inducible genes and signaling cascades such as HSPs and oxidative
stress-activated pathways (Abdelmohsen et al., 2008; Amadio
et al., 2008). HO-1 gene product and its mRNA abundance
is controlled at various stages and it was reported that HO-1
induction by nitric oxide (NO) is regulated by the HuR/ELAV.
Interestingly, the HuR/ELAV was found to associate with HO-1
mRNA, and this interaction increased following NO treatment
(Kuwano et al., 2009). The HO-1 chemical inducer hemin is a
highly reactive compound exhibiting pro-oxidant properties in
several biochemical reactions. In the present study, we investi-
gated, in SH-SY5Y human neuroblastoma cells, the expression
of HO-1 mRNA and protein following hemin exposure and
whether in these conditions HO-1 mRNA may represent a target
of ELAV RBPs.
MATERIALS AND METHODS
CELL CULTURES AND TREATMENTS
The SH-SY5Y human neuroblastoma cells were grown in
Eagle’s minimum essential medium supplemented with 10% fetal
calf serum, 1% penicillin-streptomycin, L-glutamine (2 mM),
nonessential amino acids (1 mM), and sodium pyruvate (1 mM)
at 37◦C in an atmosphere of 5% CO2 and 95% humidity, as
previously described (Racchi et al., 2003). The cells were exposed
to the solvent (PBS) or to hemin (50 or 100 µM as reported in
figure legends) for 2 h.
REVERSE-TRANSCRIPTION AND REAL-TIME QUANTITATIVE
POLYMERASE CHAIN REACTION (qPCR)
Total RNA was extracted from cells using the RNeasy Micro
Kit (Qiagen, Milan, Italy). The reverse transcription was per-
formed following standard procedures. PCR amplifications were
performed using the LightCycler instrument (Roche Molecular
Biochemicals) in the presence of QuantiTect SYBR Green PCR
mix (Qiagen, Milan, Italy), with primers designed by using the
PRIMER3 software.1 Primer sequences were as follows: HO-1,
5′-AGC AAC AAA GTG CAA GAT TCT GC-3′ (forward); 5′-
CAG CAT GCC TGC ATT CAC ATG-3′ (reverse); product size:
161 bp; RPL6 (Ribosomal Protein L6), 5′- AGA TTA CGG AGC
AGC GCA AGA TTG-3′ (forward), 5′-GCA AAC ACA GAT CGC
AGG TAG CCC-3′ (reverse). RPL6 mRNA was chosen as the ref-
erence mRNA on which HO-1 was normalized because this RNA
remained substantially stable during the treatments. Since RPL6
mRNA does not bear ARE sequences, it was also used as negative
control in the immunoprecipitation experiments coupled with
real-time quantitative polymerase chain reaction (qPCR).
IMMUNOPRECIPITATION
Following treatment, SH-SY5Y cells were harvested and homog-
enized in a buffer [containing 20 mM Tris-HCl (pH 7.4),
2 mM EDTA, 0.5 mM EGTA, 50 mM 2-mercaptoethanol,
0.32 mM sucrose, and a protease inhibitor cocktail] by using a
teflon/glass homogenizer. Immunoprecipitation was performed
1http://bioinfo.ut.ee/primer3-0.4.0/primer3/input.htm
on total homogenates according to a previously published pro-
tocol (Amadio et al., 2009). Briefly, immunoprecipitation was
carried out at room temperature for 2 h using 1 µg of anti-ELAV
antibody (Santa Cruz Biotech, CA, USA) per 50 µg of proteins
diluted with an equal volume of 2× Immunoprecipitation Buffer
[2% Triton X-100, 30 mM NaCl, 20 mM Tris-HCl (pH 7.4),
2 mM EDTA, 2 mM EGTA, 0.4 mM sodium vanadate, protease
inhibitor cocktail and a RNAase inhibitor] in presence of 50 µl
of protein A/G plus agarose beads (Santa Cruz Biotech, CA,
USA) previously blocked with 5% BSA in PBS. The samples were
finally subjected to RNA extraction and reverse transcription.
The negative control was obtained in the same conditions, but
in presence of an irrelevant antibody with the same isotype of
the specific immunoprecipitating antibody. For binding assay,
100 µl of the immunoprecipitation mixes were collected from
each sample and used as “input signal” to normalize the real-
time qPCR data. For both HO-1 and RPL6, the mRNA content
present in the immunoprecipitated pellet has been normalized on
the mRNA amount present in the relative “input signal”.
WESTERN BLOTTING
Total lysate were diluted in 2× sodium dodecyl sulfate (SDS) pro-
tein gel loading solution, boiled for 5 min, separated by 12% SDS-
polyacrylamide gel electrophoresis, and then processed following
standard procedures. The antibodies anti-ELAV, anti-HO-1, and
anti-α-tubulin (Santa Cruz Biotechnology, Santa Cruz, CA) were
diluted in TBST buffer [10 mM Tris-HCl, 100 mM NaCl, 0.1%
(v/v) Tween 20, pH 7.5] containing 5% milk. The nitrocellulose
membranes were processed with Pierce ECL Plus from Thermo
Scientific (Rockford, IL, USA). The experiments were performed
at least on three different cell preparations using α-tubulin to
normalize data. Densitometric analysis was performed using the
NIH Image software.2
DATA ANALYSIS
For statistical analysis the GraphPad Instat statistical package
(version 3.05 GraphPad software, San Diego, CA, USA) was
used. The data were analyzed by analysis of variance (ANOVA)
followed, when significant, by an appropriate post hoc comparison
test, as indicated in figure legends. Differences were considered
statistically significant when p values ≤ 0.05.
RESULTS
HEMIN INCREASES HO-1 mRNA LEVELS IN SH-SY5Y CELLS
To determine whether hemin treatment affects HO-1 expression
in human neuroblastoma SH-SY5Y cells, we first measured HO-
1 mRNA levels in total homogenates of cells treated with hemin
(100 µM) for 2 h + 4 h recovery. Real-time qPCR data demon-
strated a marked increase of HO-1 mRNA level in 2 h hemin-
treated samples followed by 4 h recovery as compared to the other
samples (Figure 1). RPL6 mRNA level remained substantially
stable during the experiments (data not shown). These data
reveal that in SH-SY5Y cells hemin treatment up-regulates the
expression of HO-1 mRNA.
2http://rsb.info.nih.gov/nih-image
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FIGURE 1 | Effect of hemin exposure on HO-1 mRNA levels.
Determination of HO-1 mRNA levels by real-time qPCR in human
neuroblastoma SH-SY5Y cells following treatments with 100 µM hemin for
2 h + 4 h recovery (rec). HO-1 mRNA contents are expressed as means of
the cycle threshold (Ct) ± S.E.M. **p < 0.01, Dunnett Multiple
Comparisons Test, n = 5.
ASSOCIATION OF HO-1 mRNAWITH ELAV RBPs
To test the hypothesis that ELAV RBPs interact with HO-1 mRNA
following hemin treatment, we performed an immunoprecipi-
tation assay on SH-SY5Y cells, which express all the four iso-
forms of ELAV proteins, followed by real-time qPCR. As shown
in Figure 2, the association of ELAV RBPs with HO-1 mRNA
occurs; indeed, we found that the amount of HO-1 transcript
bound by ELAV proteins in the total homogenate is increased
following 2 h hemin stimulus + 4 h recovery (Figure 2). More-
over, the housekeeping RPL6 mRNA was almost undetectable in
the same immunoprecipitated pellets (Figure 2), confirming the
existence of a specific binding between ELAV proteins and HO-1
mRNA.
HEMIN TREATMENT UPREGULATES HO-1 PROTEIN LEVELS IN A
CONCENTRATION-DEPENDENT MANNER
We finally measured HO-1 protein levels by Western blotting,
finding an increase after 2 h hemin exposure followed by 4 h
recovery (Figure 3). Interestingly, in basal conditions, HO-1 pro-
tein content is almost undetectable and its increase is proportional
to hemin concentration, reaching statistical significance only at
100 µM concentration (Figure 3). In the same samples we also
measured ELAV proteins levels, finding they are not modified
following hemin stimulus (not shown).
DISCUSSION
HO-1 is one of the main players of the endogenous antioxidant
responses and since it provides cytoprotection against various
neurotoxic insults, it is crucial to elucidate how HO-1 gene
expression is regulated. A comprehensive knowledge regarding
HO-1 expression in human neural cells is still lacking. Although
most studies have focused on the molecular mechanisms respon-
sible for the cytoprotective effects of HO-1, the importance
of post-transcriptional processes in the modulation of HO-1
gene expression has been greatly underestimated. Furthermore,
there is an emerging consensus that neuronal transcripts are
FIGURE 2 | ELAV proteins specifically bind to HO-1 mRNA.
(A) Schematic representation of the procedure of the
RNA-immunoprecipitation (RIP) coupled with the real-time qPCR to
determine the interaction between ELAV proteins and HO-1 mRNA (left)
and representative real time qPCR melting curves with the corresponding
amplification plots (right). Ab: antibody (B) Fold enrichment detected by
real-time qPCR of HO-1 and RPL6 (housekeeping) mRNAs in control (CTR)
and 2 h hemin-treated + 4 h recovery (rec) SH-SY5Ycells following
immunoprecipitation with the anti-ELAV antibody. ***p < 0.001,
Tukey-Kramer Multiple comparisons test, n = 3.
differentially processed in the brain than in other tissues (Darnell,
2013). Interestingly, it was recently demonstrated that RBPs
and non-coding RNAs are critical components underlying the
post-transcriptional mechanisms for the coordinate regulation of
mRNA expression in neuronal systems (Loya et al., 2010). Human
ELAV RBPs are involved in the post-transcriptional control of
several early-responsive genes such as MYC, FOS and cytokines
(Keene, 2007; Papadopoulou et al., 2013). Since HO-1 system is
a promising approach to treat specific disorders and its induc-
tion has significant consequences in the CNS, the present study
explores the role of ELAV proteins in the regulation of HO-
1 expression at both mRNA and protein levels. In particular,
we treated human neuroblastoma SH-SY5Y cells with hemin, a
pro-oxidant molecule. Although HO-1 is activated by various
electrophilic compounds including polyphenols (Davinelli et al.,
2013), hemin is one of the most effective stressors in terms of
reactive oxygen species (ROS) production and it is widely used to
study HO-1 function. Therefore, we chose hemin as a challenge
for our experiments. However, it is essential to point out that
at elevated concentrations hemin may contribute to cell injury
by cytotoxic effects, although strengthening endogenous defense
against oxidative stress, at nontoxic concentrations its therapeutic
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FIGURE 3 | Hemin treatment affects HO-1 protein total levels in
SH-SY5Y human neuroblastoma. (Upper) Representative Western
blotting of HO-1 and α-tubulin in control (CTR) and hemin-treated SHSY5Y
cells. Cells were exposed to either 50 or 100 µM hemin for 2 h followed by
4 h recovery (rec). (Lower) Mean gray levels ratios (mean ± S.E.M.)
expressed as percentages with respect to control (100%) of HO-1/α-tubulin
immunoreactivities measured by Western blotting. *p < 0.05; **p < 0.005,
Tukey-Kramer Multiple comparisons test, n = 3.
potential has been reported in multiple acute injury models,
including those at brain level (Lu et al., 2014). In our study, we
found that HO-1 expression is induced in 100 µM hemin-treated
neuronal cells, as demonstrated by real time qPCR and Western
blotting experiments (Figures 1, 3). This finding is consistent with
previous studies showing the activation of HO-1 by hemin in
human neuroblastoma cells (Nakaso et al., 2003). Interestingly,
and in accordance with previous evidence in rat hippocampal
neurons (Scapagnini et al., 2004), we observed that, in human
SH-SY5Y neuroblastoma cells, HO-1 protein expression is almost
absent in basal conditions and it is strongly induced by hemin
in a concentration-dependent manner (Figure 3). However, we
cannot exclude that the sensitivity of Western blotting technique
is not sufficient to detect very low amount of protein as in
control cells. The hemin-induced increase of HO-1 protein may
be due to a positive regulation of HO-1 at post-transcriptional
level. Indeed, our results shows a specific association between
ELAV and HO-1 mRNA (Figure 2), suggesting that this bind-
ing may have potential consequences for HO-1 protein expres-
sion. Our hypothesis is that HO-1 is present as mRNA in
control cells so that, as many early response genes, it can be
rapidly translated following a specific stress stimulus, such as
hemin exposure, thus contributing to the physiological cellular
response.
Although it was well-established that HO-1 is highly inducible
by a large number of stressful stimuli such as heme or certain
other metalloporphyrins, the regulation of gene expression and
FIGURE 4 | Flow chart depicting the ELAV/HO-1 cascade, in which an
oxidative stress stimulus favors ELAV proteins binding to HO-1 mRNA,
producing an increase of HO-1 expression at post-transcriptional level.
See the text for more details.
induction of HO-1 is complicated by the fact that its regulatory
response is not restricted to heme or other physical and chemical
factors. A purpose of this study was to bridge the significant gap
in understanding the regulation of HO-1 induction in neural
cells. Previous evidence from our group showed that the ELAV
RBPs are involved in regulating the post-transcriptional fate of
HSP70 and SOD-1 mRNA following H2O2-mediated oxidative
stress in SH-SY5Y cells (Amadio et al., 2008; Milani et al.,
2013). HSP70, SOD-1 and HO-1 modulate crucial defensive
mechanisms for neurons exposed to an oxidant challenge. Con-
sistently with the data reported for the other genes, the results
described in this report suggest a novel role for ELAV RBPs
in regulating, post-transcriptionally, HO-1 expression in SH-
SY5Y neuronal cells, as schematically represented in Figure 4.
Future studies are needed to identify whether this interaction is a
characteristic feature of HO-1 induction during the cellular stress
response.
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